From: Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG
 | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total cohort (n = 1887) | SA group (n = 599) | UA group (n = 1028) | AMI group (n = 260) | |||||||||||||
Euroscore II | 0.121 | 0.746 | 0.684–0.808 | 0.000 | 0.223 | 0.727 | 0.641–0.813 | 0.004 | 0.987 | 0.765 | 0.670–0.860 | 0.000 | 0.193 | 0.772 | 0.619–0.925 | 0.004 |
New evaluation system | 0.326 | 0.771 | 0.702–0.840 | 0.000 | 0.133 | 0.831 | 0.742–0.921 | 0.000 | 0.870 | 0.690 | 0.568–0.813 | 0.004 | 0.071 | 0.813 | 0.709–0.918 | 0.001 |
 | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cTnT group (n = 971) | SA group (n = 243) | UA group (n = 567) | AMI group (n = 161) | |||||||||||||
Euroscore II | 0.407 | 0.769 | 0.676–0.862 | 0.000 | 0.384 | 0.699 | 0.494–0.904 | 0.332 | 0.959 | 0.725 | 0.587–0.863 | 0.070 | 0.437 | 0.841 | 0.717–0.966 | 0.002 |
New evaluation system | 0.507 | 0.774 | 0.668–0.879 | 0.000 | 0.810 | 0.724 | 0.497–0.951 | 0.275 | 0.369 | 0.699 | 0.550–0.848 | 0.018 | 0.485 | 0.906 | 0.820–0.992 | 0.000 |
 | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P | H–L | AUC | 95%CI (%) | P |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hs-cTnT group (n = 916) | SA group (n = 356) | UA group (n = 461) | AMI group (n = 99) | |||||||||||||
Euroscore II | 0.272 | 0.747 | 0.671–0.822 | 0.000 | 0.054 | 0.762 | 0.672–0.852 | 0.002 | 0.893 | 0.822 | 0.703–0.941 | 0.003 | 0.060 | 0.646 | 0.344–0.947 | 0.391 |
New evaluation system | 0.405 | 0.782 | 0.694–0.869 | 0.000 | 0.132 | 0.849 | 0.794–0.905 | 0.000 | 0.664 | 0.736 | 0.490–0.982 | 0.032 | 0.699 | 0.715 | 0.456–0.975 | 0.206 |